LWM
DGX icon

Lyons Wealth Management’s Quest Diagnostics DGX Stock Holding History

Lyons Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-13,838
Closed -$801K – 82
2014
Q1 		$801K Buy
+13,838
New +$742K 0.7% 22
2013
Q4 		– Sell
-5,163
Closed -$320K – 67
2013
Q3 		$320K Buy
+5,163
New +$309K 0.29% 45

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Lyons Wealth Management's DGX Position: Q2 2014 in Review

Lyons Wealth Management sold out of Quest Diagnostics (DGX) in Q2 2014, closing a stake of 13,838 shares — an estimated $801K sold.

Lyons Wealth Management first reported a position in DGX in Q3 2013 and held it in 2 quarters. The position peaked at $801K in Q1 2014. 496 funds tracked by Wall St. Rank hold DGX as of Q2 2014.

  • Lyons Wealth Management reported no remaining Quest Diagnostics position as of Q2 2014 after selling out during the quarter.
  • Lyons Wealth Management sold 13,838 Quest Diagnostics shares in Q2 2014, an estimated $801K.
  • Lyons Wealth Management first reported a position in Quest Diagnostics in Q3 2013 and held it in 2 quarters.
  • Lyons Wealth Management's Quest Diagnostics position peaked at $801K in Q1 2014.
  • 496 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2014.

Based on Lyons Wealth Management's 13F filing for Q2 2014, filed 11 Aug 2014.